Senior International Medical Digital Manager

Location: Ingelheim, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
As Senior International Digital Medical Manager you will accelerate the adoption of digital within the specific Medical Therapeutic Area and live your passion of thinking outside of the box. You will be part of a dynamic team where you will have the opportunity to use your creative skills and digital mindset to provide a unique Boehringer Ingelheim customer experience.

Tasks & responsibilities

  • As Senior International Medical Digital Manager you create a plan to catalyse the medical digital transformation within the Therapeutic Area (TA) Oncology at Boehringer Ingelheim.
  • You will align with the Digital Manager and the Medical Affairs brand lead in order to ensure an optimal customer journey which is aligned with our brand and customer plans.
  • Furthermore, you will co-create the TA content to be innovative, cutting-edge and strategic as well as desirable and usable for the local country implementation, for example multi-channel content, videos, infographics and webinars.
  • In your new role you set key performance indicators to ensure measurability and the track user journey.
  • Last but not least you identify innovations that can evolve or transform the TA customer experience within the complex regulatory environment.

Requirements

  • Registered Medical Practitioner, Master of Science or PhD; experience in Therapeutic Areas/Oncology preferred
  • A minimum of 5 years of work experience regarding the following:
    • Significant medical experience within healthcare
    • Effective digital mindset to innovate, create the strategy and fully execute
    • Ability to implement new digital opportunities
    • Substantial experience in mix of local and international roles
    • Experience in a matrix organization and in cross-functional teams
  • Fluent English both written and spoken, German would be a plus

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best eHealth talent! For further information, please contact us.

Most Popular Now

Open Call SC1-DTH-01-2019: Big Data and …

Currently available methods and strategies for diagnosis and treatment of cancer help clinicians continuously improve quality of care and prevent cancer deaths in the population. Accurate risk assessment, availability of...

Cerner Selected for NHS Framework to Sup…

Integrated Care Systems (ICS) and Sustainability and Transformation Partnerships (STPs) aim to deliver the best possible quality of health and care, shift to value-based care and proactively improve outcomes for...

Brainlab and Magic Leap Partner in Digit…

Brainlab has announced a strategic development partnership with Florida-based Magic Leap, a developer of proprietary spatial computing solutions that help users enrich their real world experience by integrating digital content...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Satellites...

Whole-Brain Connectome Maps Teach Artifi…

Medical University of South Carolina (MUSC) neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of...

MEDICA 2018: The Starting Block for Many…

12 - 15 November 2018, Düsseldorf, Germany. MEDICA, the world’s leading medical trade fair in Düsseldorf which attracts over 5,000 exhibitors from around 70 countries, is becoming an even bigger hotspot...

MEDICA 2018 Presents the Future of Medic…

12 - 15 November 2018, Düsseldorf, Germany. Artificial intelligence, Big Data or IoT (Internet of Things) - we would be hard pressed to find a sector that doesn’t have these terms...

Artificial Intelligence for Health: ITU …

The ITU Focus Group on 'AI for Health' (FG-AI4H), created in collaboration with the World Health Organization (WHO), has issued a Call for Proposals to identify compelling use cases of...

Siemens Healthineers and STORZ MEDICAL P…

On the occasion of the 70th annual congress of the German Society for Urology, DGU, Siemens Healthineers and STORZ MEDICAL have announced plans to enter into a sales partnership agreement...

Spinal Cord Stimulation, Physical Therap…

Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between...

Sandoz Healthcare Access Challenge #Sand…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global competition that invites entrepreneurs and innovators...

Connecting Care Goes Live with a Care Co…

The Connecting Care Interoperability Programme has gone live with its first Care Connect FHIR API so staff working with homeless and vulnerable people can see if they have a prescription...